drugset / Trial / NCT02202005
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
Non-randomizedCrossoverOpen-label
Summary
The objective of this steady state pivotal study is to compare the rate and extent of absorption and to evaluate Bioequivalence of test drug compared to the approved reference product in HIV infected individuals
Timeline
- Start
- 2014-08
- Primary completion
- 2015-07
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nevirapine | Small molecule | 400 mg | — |
Indications
No indication recorded.